Financial results for the quarter and half year ended September 30, 2026

Ref: IIL/SE/2026/0511/01 Date: November 05, 2026 The Manager Listing Compliance Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited (Through BSE Listing Centre) (Through NEAPS) Scrip Code: 532851 Symbol: INSECTICID Dear Sir/Madam, Re: Outcome of the Board Meeting This has reference to our letter no.: IIL/SE/2026/2509/01 dated September 25, 2026 and IIL/SE/2026/2410/01 dated October 24, 2026. The Board of Directors of the Insecticides (India) Limited, at their meeting held today i.e November 05, 2026 has inter alia considered and approved the following(s): A. Financial Results: Considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company, for the Quarter and half year ended September 30, 2026 along with Limited Review Report of M/s S S Kothari Mehta & Co., LLP and M/s Devesh Parekh & Co., Joint Statutory Auditors of the Company on the Financial Statements. The Financial Results were reviewed and recommended by the Audit Committee. Accordingly, we enclosed the following as Annexure I: ● Un-audited Standalone and Consolidated Financial Results for the Quarter and half year ended on September 30, 2026. ● Limited Review Report of the Statutory Auditor(s) on the Un-audited Standalone and Consolidated Financial Results for the Quarter and half ended on September 30, 2026. A copy of the said results together with the Limited Review report are also being made available on the website of the Company at www.insecticidesindia.com. B. Dividend Declaration: 1) Interim Dividend: Declared an Interim Dividend of Rs. 5 per equity shares [50%] of face value of Rs. 10/- each for financial year 2026-2027. 2) Record Date: The record date as informed for the purpose of determining the entitlement of the shareholders for the payment of Interim Dividend is Thursday, 12th day of November, 2026 and the Interim Dividend will be paid to the shareholders, subject to deduction/withholding of applicable taxes, within the time prescribed under law. The Interim Dividend will be paid on or after November 17, 2026 C. Appointment of Independent Director (Additional) and Senior Management Personnel of the Company: 1) On the recommendation of the Nomination Remuneration and Ethics Committee, the Board of Directors approved the appointment of Mr. Veera Bhadram Garimella (DIN: 00114611) as an Independent Director (Additional) of the Company for a term of five consecutive years effective from November 05, 2026 till November 04, 2031 (both days inclusive), not liable to retire by rotation, subject to approval of the shareholders through postal ballot. The process, timelines and other requisite details of the postal ballot will be communicated in due course. 2) On the recommendation of the Nomination Remuneration and Ethics Committee, the Board of Directors approved the appointment of Mr. Kapil Sharma as AVP- Tech. Services Projects and Manufacturing Excellence, a Senior Management Personnel (SMP) of the Company w.e.f November 05, 2026. Brief profile and other details w.r.t item no. 1&2 above as required under regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2 / I/3762/2026 dated January 30, 2026 are enclosed as Annexure II. D. Offer of Shares under Insecticides (India) Limited Employees Stock Purchase Scheme 2026 (“IIL ESPS Scheme 2026/Scheme”). 1) The Nomination and Remuneration and Ethics Committee has Considered and approved grant of 19,393 (Nineteen Thousand Three Hundred and Ninety-Three) Equity Shares of Rs. 10/- each of the Company to Eligible Employees of the Company and its wholly owned Subsidiaries under the Company’s “IIL ESPS Scheme 2026” as approved by the Shareholders in the 29th Annual General Meeting held on August 12, 2026 and in- principle approval granted by NSE and BSE vide respective in-principle letters dated October 19, 2026 respectively. The disclosures as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2 / I/3762/2026 dated January 30, 2026 are enclosed as Annexure III. The Board meeting commenced at 01:00 PM (IST) and concluded at 3:00 PM (IST). You are requested to kindly take on records. Thanking You, For Insecticides (India) Limited (Sandeep Kumar) Company Secretary & CCO Encl: As above Insecticides (India) Limited CIN· L6599 l DL I 996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi • 110 033; Telefax· 01 I-27679700 -05; Website: www.insecticidesindia.com; E-mail: investor@insecticidesindia com STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR TIIB QUARTER AND HALF YEAR ENDED SEPTEMBER 30, 2026 (( In lacs, except EPS) Quarter Ended Half Year Ended Year Ended SI No. Particulars 30-09-2026 30-06-2026 30-09-2025 30-09-2026 30-09-2025 31-03-2026 (Unaudited) (Unaudited) rt lnaudited' (Unaudited) /Unaudited) (Audited I Revenue from operations 68,017.57 61,648.22 64,124.89 1,29,665.7 9 1,33,262 13 2,14,414.11 II Other Income (88.49 462.36 267.44 373.87 641.95 I 211 12 Ill Total Income (l+ID 67 929.08 62 1I0.58 64 392.33 130 039.66 I 33 904.08 2 IS 625.23 IV Expenses (a) Cost of materials consumed 41,081.23 38,641 98 36,791 02 79,723.21 75.554 72 1,24,564.76 (b) Purchase ofStock-rn-Trade 6,582.70 7,670 83 4,854.87 14,253.53 7,803.96 13,290.04 (c)Changes m inventories of finished goods, work-in-progress and stock-in- (1,331.40) {3,390.20) 1.122 25 (4,721 60) 8,529.90 10,37548 trade (d) Employee benefits expense 5,130.12 4,498.34 4,694 29 9,628.46 8,800 11 15,984 90 (cl Finance costs 640.52 464.98 407.57 1,105.50 772 55 1,651.20 (t) Depreciauon and amonization expense 972.39 959.27 927.07 1,931.66 1,654.83 3,521 60 ( ~} Other expenses 8 058.93 7 638.91 8 176.04 15 697.84 15 683.96 28 039 55 Total expenses 61 134.49 56 484.11 56 973.11 117618.60 I 18 800.03 I 97 427.53 V Profit before tax (Jrl-lV) 6 794.59 5 626.47 7 419.22 12 421.06 IS 104.05 18 197.70 VI Ta:\ Expense (I) Current Tax 1,842.20 1,574.27 1,900.71 3,416.47 3,740.19 4,224.13 (2) Deferred Tax (105.20) /130.85) 1)2.511 /236 05) 102.79 391.83 Total Tax Ex1,ense I 737.00 I 443.42 1 888.20 3 180.42 3 842.98 4 615.96 Vil Profit/ (loss) for the period/year (V-\11) 5 057.59 4 183.05 5 531.02 9 240.64 II 261.07 13 581.74 VlJJ Other comprehensive income A Items that will not be reclassified to profit or loss (i) Changes in fair value ofFVTOCI equity instnuncnts 208.49 (177.10) 215.40 31.39 242.49 407.98 (ii) Remeasurement of net defined benefit plans (31.25) (31.25) (35 00) (62.50) (70.00) ( 122 11} (1i1) Income Jax relating to these items (40.70\ 49 12 141.37\ 8.42 /38.87) (64 31) Other comprehensive income for the period/year (net of tax) 136.54 1159.23) 139.03 122.69\ 133.62 221.56 IX T~tal comprehensive income for the period/year (Vll+Vlll) S 194.13 4 023.82 5 670.05 9 217.95 11 394.69 13 803.30 Paid up equity share capital (Face value t 10/-each) 2,909.78 2,909.78 2,909.78 2,909.78 2,909 78 2,909 78 Other Equity . - I, 18,490.59 Earnings per share (oft 10 each) (not annualised): (a} Basic 17.38 14.38 19.01 31.76 38.70 46.68 (b) D1lu1cd 17.38 14.38 19.01 31.76 38.70 46.68 (Note EPS for respecuvc quaners arc not annualized) :--'ates: I The above Unaudncd Standalone Financial Results have been published in accordance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligauons and D1sclosuI"C Rcqum;mcnts) Rcgulacions, 201S. as amended. 111c results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their mectmg held on November 05, 2026. The Statutory Auditors have carried out a limited review of financial results. The Limited Review Repon and Quanerly Financial Results are available on the Stock Exchange website at www.bseindia.com, www.nseindia.com and on the Company's website www.insecticidesindia.com. 2 The above Unaudit [Showing first 8,000 characters — download PDF for full document]